Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
04:55:29 EDT Fri 17 May 2024
Enter Symbol
or Name
USA
CA



EGF Theramed Health Corp (2)
Symbol TMED
Shares Issued 10,491,161
Close 2023-07-05 C$ 0.42
Market Cap C$ 4,406,288
Recent Sedar Documents

EGF Theramed appoints Shao as director

2023-07-05 19:13 ET - News Release

Subject: 2023-07-05 EGF Theramed - Press Release - Jackie PDF Document File: Attachment 2023-07-05 EGF Theramed - Press Release - Jackie.pdf EGF THERAMED APPOINTS SHAO AS DIRECTOR Vancouver, British Columbia--(July 5th, 2023) - EGF Theramed Health Corp. (CSE: TMED) (OTC Pink: EVAHF) (FSE: AUHP) (the "Company" of "EGF") announces the appointment of Jackie Shao to the board of directors following the resignation of George Anstey. Mr. Shao is a seasoned digital marketing expert with experience consulting multiple companies on their sales and marketing growth strategies. Reporting directly to the board and CEO, Jackie Shao has managed a broad range of responsibilities in the highly complex and regulated commodities industry in Geyser Brands Inc. Jackie also brings a creative edge leveraging a Bachelor's Degree in environmental design from the prestigious Art Center College of Design in Los Angeles. Jackie has used his expertise in sales and marketing to scale multiple companies from start-up to seven figure valuations. Playing a crucial role in Conquest Capital and 113 Royal Investments. Jackie has played an instrumental part in identifying the best emerging assets that Conquest Capital has acquired. Having extensive experience in M&A and a valuable network, Jackie marks as a strategic fit for the Company. The Company would like to thank Mr. Anstey for his contributions over the years and wishes him well in his future endeavours. ABOUT EGF THERAMED HEALTH CORP. (CSE: TMED) (OTC Pink: EVAHF) (FSE: AUHP) EGF is a consumer technology company engaged in the provision of biomedical online services for monitoring and treating common health problems. The Company, through its subsidiaries, has assets and technologies used in the extraction and purification of botanical extracts and the creation of extract formulations, as well as medical monitoring device technology. The Company is working to collaborate with other companies for medical technology, equipment protocols and laboratory SOPs. For more information please contact: EGF THERAMED HEALTH CORP. Connor Yuen Email: connoryuen@conquestvc.com Telephone: 778 999-3353 Website http://www.theramedhealthcorp.com CSE Micro-site: http://thecse.com/en/listings/technology/Theramed-Health-Corporation US OTC Markets (OTCQB): http://www.otcmarkets.com/stock/EVAHF/news Frankfurt Borse: http://www.boerse-frankfurt.de/equity/egf-theramed-health-corp-1 CAUTIONARY LANGUAGE All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws, including with respect to the completion of the Transaction contemplated by the Term Sheet. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company's public filings under the Company's SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

© 2024 Canjex Publishing Ltd. All rights reserved.